This result is also supported by an in vitro experiment (performed in hepatocytes in which steatosis was induced by free fatty acids exposure) suggesting that liraglutide has a protective effect on hepatic steatosis which is mediated by the activation of autophagy flux particularly throughout the AMPK/mTOR pathway (Liao et al., 2024). The gene discussed is MTOR; the disease is fatty liver disease.